Ozagrel Sodium for Injection – Quality Thromboxane A2 Synthase Inhibitor

SKU:
Procurenet
Short description

Ozagrel Sodium for Injection is a potent thrombin A2 synthase inhibitor used for acute thrombotic cerebral infarction treatment and associated movement disorders. Its key merits include a high efficiency as a thrombin A2 synthase inhibitor, notable inhibition of platelet synthesis, potent thrombosis prevention, blood vessels dilation, and blood flow increment, making it a preferred choice in clinical medicine. The main active ingredient is ozagrel sodium, administered intravenously under professional healthcare supervision. Indications primarily include acute thrombotic cerebral infarction and related movement disorders. Store at controlled room temperature (20-25°C) away from light. Product availability is in injection vials.

$0
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only
Description

Presenting Ozagrel Sodium for Injection, a highly potent and specific Thromboxane A2 (TXA2) synthase inhibitor widely used in the medical sphere for the treatment of acute ischemic stroke and related mobility disorders. Offering a precise mechanism of action, Ozagrel Sodium for Injection stands out for its excellent ability to inhibit platelet aggregation, avert thrombosis, enlarge blood vessels, and facilitate augmented blood circulation.

  • Skilled and selective Thromboxane A2 synthase inhibitor.
  • Notably suppresses platelet production and aggregation.
  • Functions effectively to prevent thrombus formation.
  • Fosters dilation of blood vessels, assisting elevated circulation.
  • Boosts blood flow, promoting overall cardiovascular health.
  • Recognized for its high potency and proven safety record in the medical field.

Used as a proactive approach to treat and manage acute thrombotic cerebral infarction or ischemic stroke, Ozagrel Sodium for Injection exhibits an exceptional safety profile. It works directly to inhibit the synthesis of thromboxane A2, a compound that plays a significant role in forming blood clots. By doing so, it aids in preventing thrombus or clot formation, one of the leading causes of stroke events.

The product's superb efficiency to increase blood flow is achieved by dilating the blood vessels, which helps in preventing ischemic conditions where the supply of oxygenated blood is limited to the tissues. As such, it provides valuable protection against stroke-associated mobility disorders, boosting patient prognosis and recovery.

While the data concerning LD50, CAS number, Bioassay Results, Pharmacological Class, etc., is not known specific to Ozagrel Sodium for Injection, the product has been trusted and selected for its safety and effectiveness in clinical medicine.

All categories
Filters